欧盟的优先药物激励制度研究

摘要

加快药品审批效率,促进药品创新已经成为行业共识.本文通过分析欧盟优先药物激励制度实施背景及其激励措施,结合我国当前特殊审评的现状,探讨如何完善我国特殊审评制度.%It is the consensus for the industry and government to enhance drug approval efficiency and promote drug innovation.This paper tries to analyze the background and incentive measures of PROority MEdicines in the Europe Union and discusses how to accelerate the evaluation process in our country based on the existing framework.